| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Arvee Laboratories (India) Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹190.00 |
| 52 Week High | ₹315.00 |
| 52 Week Low | ₹103.60 |
| Beta | 0.50 |
| 11 Month Change | 2.79% |
| 3 Month Change | 33.85% |
| 1 Year Change | 55.36% |
| 33 Year Change | 66.96% |
| 5 Year Change | 544.07% |
| Change since IPO | 508.00% |
Recent News & Updates
Recent updates
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Might Deserve Your Attention Today
Aug 08
Here's Why We Think Arvee Laboratories (India) (NSE:ARVEE) Is Well Worth Watching
Apr 13Do Arvee Laboratories (India)'s (NSE:ARVEE) Earnings Warrant Your Attention?
Dec 22We Ran A Stock Scan For Earnings Growth And Arvee Laboratories (India) (NSE:ARVEE) Passed With Ease
Sep 16Subdued Growth No Barrier To Arvee Laboratories (India) Ltd.'s (NSE:ARVEE) Price
Aug 13Calculating The Intrinsic Value Of Arvee Laboratories (India) Ltd. (NSE:ARVEE)
Apr 19Shareholder Returns
| ARVEE | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -3.5% | 2.9% | -0.1% |
| 1Y | 55.4% | 22.7% | 46.3% |
Return vs Industry: ARVEE exceeded the Indian Chemicals industry which returned 22.7% over the past year.
Return vs Market: ARVEE exceeded the Indian Market which returned 46.3% over the past year.
Price Volatility
| ARVEE volatility | |
|---|---|
| ARVEE Average Weekly Movement | 12.4% |
| Chemicals Industry Average Movement | 6.1% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: ARVEE's share price has been volatile over the past 3 months.
Volatility Over Time: ARVEE's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2012 | 67 | Shalin Patel | arveelabs.com |
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4–amino pyridine, and 2–chloro–5–nitrobenzoic acid.
Arvee Laboratories (India) Ltd. Fundamentals Summary
| ARVEE fundamental statistics | |
|---|---|
| Market cap | ₹2.09b |
| Earnings (TTM) | ₹10.52m |
| Revenue (TTM) | ₹303.45m |
199.1x
P/E Ratio6.9x
P/S RatioIs ARVEE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ARVEE income statement (TTM) | |
|---|---|
| Revenue | ₹303.45m |
| Cost of Revenue | ₹147.95m |
| Gross Profit | ₹155.50m |
| Other Expenses | ₹144.98m |
| Earnings | ₹10.52m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.95 |
| Gross Margin | 51.24% |
| Net Profit Margin | 3.47% |
| Debt/Equity Ratio | 3.4% |
How did ARVEE perform over the long term?
See historical performance and comparison